Principal Financial Group’s DICE Therapeutics DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-10,976
Closed -$510K – 2495
2023
Q2
$510K Buy
10,976
+329
+3% +$11.4K ﹤0.01% 1948
2023
Q1
$305K Buy
10,647
+1,328
+14% +$39.3K ﹤0.01% 2083
2022
Q4
$291K Buy
+9,319
New +$304K ﹤0.01% 2105

Principal Financial Group's DICE Position: Q3 2023 in Review

Principal Financial Group sold out of DICE Therapeutics (DICE) in Q3 2023, closing a stake of 10,976 shares — an estimated $510K sold.

Principal Financial Group first reported a position in DICE in Q4 2022 and held it in 3 quarters. The position peaked at $510K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Principal Financial Group reported no remaining DICE Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Principal Financial Group sold 10,976 DICE Therapeutics shares in Q3 2023, an estimated $510K.
  • Principal Financial Group first reported a position in DICE Therapeutics in Q4 2022 and held it in 3 quarters.
  • Principal Financial Group's DICE Therapeutics position peaked at $510K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics as of Q3 2023.

Based on Principal Financial Group's 13F filing for Q3 2023, filed 2 Nov 2023.